Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Gain Therapeutics, Inc.

NASDAQ: GANX · Life Sciences · 5 alerts · CIK 1819411

Share price
$0.9402Close, Nov 16
Market cap
$41.9M
Shares outstanding
44.53MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Gain Therapeutics, Inc. filings on SEC EDGAR ↗

5:01 PM ET 8-K
Executive Compensation

Gain Therapeutics Executive Compensation

Gain Therapeutics appointed Jeanette Weidner as Vice President, Finance, and principal financial and accounting officer, effective October 28, 2026. Her compensation package includes an annual base salary of $275,000, a target annual cash bonus of 35%, and an option to purchase 130,000 shares of common stock vesting over four years.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.